Uptake and characteristics of zoledronic acid and denosumab patients and physicians in Ontario, Canada: impact of drug formulary access
Crossref DOI link: https://doi.org/10.1007/s00198-014-3023-8
Published Online: 2015-01-21
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Burden, A. M.
Tadrous, M.
Calzavara, A.
Cadarette, S. M.
Text and Data Mining valid from 2015-01-21